Skip to content

Artiva Biotherapeutics, Inc. ARTV Operating Lease Weighted Average Discount Rate Percent

Operating Lease Weighted Average Discount Rate Percent at other companies

Allogene Therapeutics logo
Allogene TherapeuticsALLO
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Revenue-
Operating income-$24.4M-10.2%
Net income-$23.5M-15.8%
EPS (diluted)-$0.95-14.5%

Balance sheet

See full
Cash & equivalents$21.4M-30.6%
Total debt$10.3M-26.7%
Total equity$87.8M-48.0%
Total assets$106.0M-44.6%

Cash flow

See full
Operating cash flow-$21.0M-5.6%
CapEx$242.0K-52.6%
Free cash flow-$21.2M-4.1%

Valuation

See full
Market cap$429.03M+1,015%
Enterprise value$417.88M+1,832%

Profitability

See full
Operating margin-83.9%
Net margin-79.3%

Returns & leverage

See full
Return on equity-67.9%
Debt / equity0.1×0.0×
Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s operating lease weighted average discount rate percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s operating lease weighted average discount rate percent?
Artiva Biotherapeutics, Inc. (ARTV) reported operating lease weighted average discount rate percent of $0.08 in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s operating lease weighted average discount rate percent changed year-over-year?
Artiva Biotherapeutics, Inc.'s operating lease weighted average discount rate percent increased by 3.9% year-over-year, from $0.08 to $0.08.
What is the long-term trend for Artiva Biotherapeutics, Inc.'s operating lease weighted average discount rate percent?
Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s operating lease weighted average discount rate percent has grown at a 1.3% compound annual growth rate (CAGR), from $0.08 to $0.08.